Boston Scientific (BSX) Change in Cash (2009 - 2026)

Boston Scientific has disclosed Change in Cash across 18 years of filings, most recently posting -$890.0 million for Q2 2026.

• In Q2 2026, Change in Cash fell 397.21% year-over-year to -$890.0 million; the TTM figure through Jun 2026 stood at $12.0 million (up 100.52% YoY), while the FY2025 annual figure was $1.5 billion, up 442.44% from the prior year.
• Change in Cash came in at -$890.0 million for Q2 2026 at Boston Scientific, down from -$504.0 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $1.4 billion in Q1 2024 to a low of -$2.0 billion in Q4 2024.
• Average Change in Cash over 5 years is -$78.6 million, with a median of -$74.0 million recorded in 2022.
• Year-over-year, Change in Cash soared 6888.89% in 2022 and plunged 2554.55% in 2024.
• Over 5 years, Change in Cash stood at $629.0 million in 2022, then sank by 112.24% to -$77.0 million in 2023, then sank by 2554.55% to -$2.0 billion in 2024, then soared by 132.83% to $671.0 million in 2025, then tumbled by 232.64% to -$890.0 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were -$890.0 million in Q2 2026, -$504.0 million in Q1 2026, and $671.0 million in Q4 2025.